Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
1.
JAMA Dermatol ; 2024 May 22.
Article in English | MEDLINE | ID: mdl-38776111

ABSTRACT

This case report describes 2 patients with metastatic Crohn disease who were treated with upadacitinib.

8.
Arch Dermatol Res ; 316(1): 49, 2023 Dec 18.
Article in English | MEDLINE | ID: mdl-38108861

ABSTRACT

Despite evidence to suggest a relationship between time of year and hidradenitis suppurativa (HS) flaring, no studies have been conducted to date to establish a relationship directly between temperature and flaring. In this study, we aim to validate a classification approach based on administrative data for identifying medical encounters that likely represent HS flares in patient with a known diagnosis of HS within the Mass General Brigham Health System (MGB) and examine the relationship between average daily temperatures and HS disease flaring among patients in Boston. This is a retrospective cohort study. Participants were individuals with HS presenting to emergency departments or dermatology outpatient clinics with disease flares between January 2017 and January 2022. The average number of encounters for HS flares was compared with the temperature for that day and the 3- and 7-day periods prior. There were 2567 patient encounters for HS flares included in the study. Of the total identified HS flares, 75.6% occurred in females and 39.1% occurred in patients who identified as Black. Uniformly small but statistically significant relationships were noted between increased temperature and presentations for hidradenitis suppurativa flare with the highest correlation coefficient (0.0768) noted with a 3-day lag time between the heat experienced and day of presentation for flare. Increased temperature is associated with a small, but statistically significant increase in HS disease flaring. As such, HS disease flaring may rise as global temperatures do, suggesting an increase in the global burden of HS as climate change persists.


Subject(s)
Hidradenitis Suppurativa , Female , Humans , Hidradenitis Suppurativa/epidemiology , Retrospective Studies , Temperature , Emergency Service, Hospital
9.
Int J Dermatol ; 62(5): 681-684, 2023 May.
Article in English | MEDLINE | ID: mdl-36912708

ABSTRACT

BACKGROUND: As the climate crisis grows, so does the global burden of displacement. Displacement, whether a direct or indirect consequence of natural disaster, can lead to dire health sequelae. Skin health is no exception to this, with dermatologic disease being a leading concern reported by those who care for displaced persons. Health professionals who provide dermatologic care for displaced persons benefit from understanding how climate change impacts the global profile of infectious agents. METHODS: This review was performed using PubMed and Google Scholar. Search terms included climate change, displaced person, internally displaced person, and refugee, as well as searches of infectious disease dermatology and the specific diseases of interest. Case reports, case series, reviews, and original research articles were included in this review. Non-English studies were not included. RESULTS: In this manuscript several key infectious agents were identified, and we discuss the skin manifestations and impact of climate change on cutaneous leishmaniasis, dengue, chikungunya, zika, malaria, pediculosis, cutaneous larva migrans, cholera, and varicella zoster. CONCLUSIONS: Climate change plays a significant role in the challenges faced by displaced persons, including their skin health. Among the many consequences of climate change is its altering of the ecological profile of infectious agents and vectors that impact displaced persons. Being familiar with this impact can improve dermatologic care for this vulnerable population.


Subject(s)
Communicable Diseases , Refugees , Transients and Migrants , Zika Virus Infection , Zika Virus , Humans , Climate Change , Communicable Diseases/epidemiology , Skin
12.
Res Sq ; 2023 Dec 22.
Article in English | MEDLINE | ID: mdl-38196608

ABSTRACT

Background: Hidradenitis suppurativa (HS) is a chronic skin disease that causes significant burden for patients in multiple aspects of their life. However, the details regarding the impact on factors aside from skin are limited. Objective: We explored patient perspectives around the impact of HS on personal health and how that affects a patient's health care decision making. Methods: Individual, semi-structured, virtual interviews were conducted with adults that have HS by a trained medical student. The interviews were performed over a private, video conference platform. English speaking individuals between the ages of 18-45 with a diagnosis of HS for at least 1 year were invited to participate in the study. The transcripts were coded by the medical student and a research assistant and discrepancies were resolved by group consensus. This study followed the reporting guidelines of the Consolidated Criteria for Reporting Qualitative Research. Results: 23 participants were interviewed in which 21 participants (91%) were female and 2 participants (9%) were male. The mean age was 31.2 years. Patients expressed an increased awareness of their personal health because of their HS, including considering HS with respect to what they ate, the medications they took, the physicians they sought, and their family planning decision. Some participants stated that HS made them more likely to receive vaccines while others described the two are unrelated. Conclusions: Patients with HS considered their skin disease when making medical decisions broadly. Many specifically considered their disease when making decisions regarding health maintenance and immunizations though some did not consider the two related.

13.
JAMA Dermatol ; 158(12): 1447-1449, 2022 12 01.
Article in English | MEDLINE | ID: mdl-36287535

ABSTRACT

This cross-sectional study examines state Medicaid coverage of human papillomavirus vaccination in adults aged 27 to 45 years and discusses the implications of the results for dermatologists.


Subject(s)
Papillomavirus Infections , Papillomavirus Vaccines , United States , Humans , Adult , Medicaid , Human Papillomavirus Viruses , Papillomavirus Infections/prevention & control , Dermatologists , Vaccination
15.
JAMA Dermatol ; 158(6): 609-610, 2022 06 01.
Article in English | MEDLINE | ID: mdl-35544078
SELECTION OF CITATIONS
SEARCH DETAIL
...